TAC-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAC-001, covering 2024-08-16 to 2024-08-16. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]